Experience with carbon-11 choline positron emission tomography in prostate carcinoma

European Journal of Nuclear Medicine

Volumn 27, Issue 9, 2000, Pages 1415-1419

  Kotzerke, Jörg ^a   Prang, Jürgen ^a   Neumaier, Bernd ^a   Volkmer, Björn ^a   Guhlmann, Albrecht ^a   Kleinschmidt, Klaus ^a   Hautmann, Richard ^a   Reske, Sven N ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Choline; Positron emission tomography; Prostate cancer; Staging

Indexed keywords

CARBON 11; CHOLINE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; LYMPH NODE METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER;

AGED; CARBON RADIOISOTOPES; CHOLINE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033864720     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590000309     Document Type: Article

References (10)

1. Combating prostate cancer
2. Metabolic imaging of untreated prostate cancer by positron emission tomography with 18fluorine-labeled deoxyglucose
3. Prostate cancer: Metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging
4. PET imaging of prostate cancer using carbon-11-choline
5. 11C]choline
6. Labeled choline and phosphorylcholine: Body distribution and brain autoradiography - Concise communication
7. 11C]choline in human subjects
8. Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer
9. 11C]methionine using whole-body positron emission tomography
10. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma